- Home
- IRON vs EPAC Comparison
IRON vs EPAC Comparison
Compare IRON & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- EPAC
- Stock Information
- Founded
- IRON 2017
- EPAC 1910
- Country
- IRON United States
- EPAC United States
- Employees
- IRON N/A
- EPAC N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- EPAC Industrial Machinery/Components
- Sector
- IRON Health Care
- EPAC Technology
- Exchange
- IRON Nasdaq
- EPAC Nasdaq
- Market Cap
- IRON 2.0B
- EPAC 2.0B
- IPO Year
- IRON N/A
- EPAC N/A
- Fundamental
- Price
- IRON $60.35
- EPAC $43.72
- Analyst Decision
- IRON Strong Buy
- EPAC Buy
- Analyst Count
- IRON 11
- EPAC 1
- Target Price
- IRON $95.73
- EPAC $53.00
- AVG Volume (30 Days)
- IRON 325.5K
- EPAC 389.7K
- Earning Date
- IRON 08-07-2025
- EPAC 10-14-2025
- Dividend Yield
- IRON N/A
- EPAC 0.10%
- EPS Growth
- IRON N/A
- EPAC 7.49
- EPS
- IRON N/A
- EPAC 1.63
- Revenue
- IRON N/A
- EPAC $608,099,000.00
- Revenue This Year
- IRON N/A
- EPAC $6.24
- Revenue Next Year
- IRON N/A
- EPAC $5.86
- P/E Ratio
- IRON N/A
- EPAC $26.03
- Revenue Growth
- IRON N/A
- EPAC 2.82
- 52 Week Low
- IRON $30.82
- EPAC $36.51
- 52 Week High
- IRON $68.73
- EPAC $51.91
- Technical
- Relative Strength Index (RSI)
- IRON 57.22
- EPAC 68.08
- Support Level
- IRON $57.54
- EPAC $41.80
- Resistance Level
- IRON $64.83
- EPAC $43.32
- Average True Range (ATR)
- IRON 2.14
- EPAC 0.98
- MACD
- IRON -0.19
- EPAC 0.30
- Stochastic Oscillator
- IRON 46.60
- EPAC 91.13
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.